Oxford Immunotec Global PLC | Mutual Funds
Mutual Funds that own Oxford Immunotec Global PLC
Invesco Perpetual UK 2 Invt. Series - Income Fund
2,683,448
10.33%
0
0.67%
03/29/2018
Polar Capital Funds Plc - Healthcare Opportunities Fund
1,975,022
7.61%
0
1.66%
07/31/2018
AXA Framlington Biotech Fund
872,828
3.36%
0
1.81%
02/28/2018
iShares Russell 2000 ETF
531,023
2.04%
-285
0.02%
09/06/2018
Invesco Perpetual UK Invt. Ser. - High Income
400,000
1.54%
0
0.05%
03/29/2018
Polar Capital Funds Plc - Biotechnology Fund
325,000
1.25%
0
0.97%
07/31/2018
Grandeur Peak International Opportunities Fund
314,130
1.21%
42,300
0.54%
04/30/2018
Grandeur Peak Global Opportunities Fund
281,879
1.09%
35,325
0.53%
04/30/2018
Wasatch Ultra Growth Fund
273,598
1.05%
102,563
2.16%
03/31/2018
JNL/Eagle Small Cap Equity Series
245,600
0.95%
0
0.17%
03/31/2018
| Address |
Milton Park
Abingdon Oxfordshire OX14 4RZ
United Kingdom
|
|
Employees
|
- |
| Website |
http://oxfordimmunotec.com |
| Updated |
07/08/2019 |
| Oxford Immunotec Global Plc operates as a medical diagnostics company, which develops and commercializes proprietary tests for under-served immune-regulated conditions. Its current product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. Its products include T-SPOT. |
